Nachrichten zur Moderna Inc. Aktie

Why is Moderna stock rallying today?…

BioNTech has billions in cash, and its oncology programs are moving into late-stage clinical trials.…

Moderna sank as Wall Street grew more cautious on the companys valuation after a massive rally this year.…

Moderna gains $4.2 billion in a week on cancer-vaccine optimism and Nasdaq-100 inclusion. Can its growth prospects justify its premium…

Vertex raised its full-year outlook in Q2 with a growing pipeline across multiple disease areas. Moderna’s mRNA flu vaccine just…

Über Moderna (MRNA) habe ich zuletzt am 17. September an dieser Stelle berichtet. Seither ist die Aktie von 160 auf…

TEM is expanding its precision medicine footprint through strategic collaborations with Moderna, Merck and Recursion, paving the way for future…

…

Moderna stock is up 663% in 2026, beating AI names for the S&P 500 lead. Full cancer vaccine data arrives…

The biotech could play a significant role in a national effort to combat cancer.…

Have Moderna’s shares risen too much, too fast?…

Modernas NASDAQ 100 debut triggered a surge in buying, but the real question is whether the rally holds once index…

…

Here are some of the companies making headlines in midday trading.…

Nach dem Corona-Boom kämpfte Moderna mit sinkenden Umsätzen. Jetzt sorgen neue Präparate, Kostensenkungen und Fortschritte beim personalisierten Krebsimpfstoff für Rückenwind.…

Nasdaq said ?on Thursday that Moderna ?will join the Nasdaq-100 Index, replacing Warner Bros. ?Discovery , ?on October 9.…

Moderna (MRNA) closed the most recent trading day at $188.94, moving 1.89% from the previous trading session.…

Detailed price information for Moderna Inc (MRNA-Q) from The Globe and Mail including charting and trades.…

Bad Marienberg (www.aktiencheck.de) - Nach einer spektakulären Rally der Aktie von Moderna Inc. (ISIN: US60770K1079, WKN: A2N9D9, Ticker-Symbol: 0QF, NASDAQ-Symbol:…

These are the stocks posting the largest moves midday.…

Moderna’s rally has priced in unrealistic expectations for its cancer drug sales.…

The company could enter a fresh growth phase.…

MRNAs respiratory vaccine expansion and promising oncology results offer potential growth as COVID-19 demand normalizes.…

These are the stocks posting the largest moves premarket.…

Premarket movers: Micron; Boeing rises, Moderna slides…

Analyst Geoff Meacham downgraded the biotech name to sell.…

Moderna, Micron, Intel and AMD have powered huge gains in single-stock leveraged ETFs in 2026. Here are four standout areas.…

Moderna (MRNA) concluded the recent trading session at $198.88, signifying a +2.08% move from its prior days close.…

Mit einem Plus von knapp sieben Prozent gehörte die Aktie von Moderna am Donnerstag erneut zu den Outperformern im S&P…

As the bulls reassert their power, leading stocks like SanDisk, Coinbase, and Moderna are setting up in constructive base structures.…

As the bulls reassert their power, leading stocks like SanDisk, Coinbase, and Moderna are setting up in constructive base structures.…

One company is growing a commercial drug business with limited margin for error on the path to profitability. The other…

NVIDIA, Advanced Micro Devices, Tempus, Moderna, Super Micro Computer and Aya Gold & Silver have been highlighted in this Investment…

Moderna (MRNA) hat bewiesen, dass die mRNA-Technologie funktioniert. Doch der Weg von einem reinen Pandemie-Profiteur zu einem breit aufgestellten Biotech-Konzern…

In the closing of the recent trading day, Moderna (MRNA) stood at $146.69, denoting a +1.89% move from the preceding…

Why is Moderna stock rallying today?…

Moderna stock surges 143% in a month on positive cancer therapy results, but competition and valuation raise key questions for…

Bad Marienberg (www.aktiencheck.de) - Bei der Aktie von Moderna Inc. (ISIN: US60770K1079, WKN: A2N9D9, Ticker-Symbol: 0QF, NASDAQ-Symbol: MRNA) treffen derzeit…

GSK PLCs (LSE:GSK, NYSE:GSK)  experimental mRNA flu vaccine produced data that closely resemble Modernas own candidate, according to Deutsche Bank....…

Shares of biotechnology company Moderna (NASDAQ:MRNA) fell 2.9% in the afternoon session after Rothschild & Co Redburn analyst Simon Baker…

…

MRNAs newly approved mFlusiva faces a potential challenge as GSK advances an mRNA flu vaccine targeting two viral proteins.…

The research firm downgraded the biotechnology stock to sell from neutral.…

CambridgeNew York (www.aktiencheck.de) - Moderna-Aktienanalyse von Argus Research:Argus habe die Aktie von Moderna Inc. (ISIN: US60770K1079, WKN: A2N9D9, Ticker-Symbol: 0QF,…

Moderna could be on the verge of a breakthrough, but the biotechs MRNA cancer vaccine catalyst is overly priced in.…

Bei Moderna war auf der Newsseite zuletzt einiges geboten. Das US-Biotech-Unternehmen meldete in der vergangenen Woche einen wichtigen Durchbruch bei…

Moderna ist ein US-Biotech-Unternehmen, das sich auf Boten-RNA (mRNA)-Medikamente spezialisiert hat. Am 19. August veröffentlichte die Firma mit Merck positive…

Bloom Energy, Micron, Nvidia, UBS and Moderna have been highlighted in this Investment Ideas article.…

Frankfurt (www.aktiencheck.de) - Moderna-Aktienanalyse von XTB:Das Biotechnologie-Unternehmen Moderna Inc. (ISIN: US60770K1079, WKN: A2N9D9, Ticker-Symbol: 0QF, NASDAQ-Symbol: MRNA) sorgt gemeinsam mit…

Nach einem von Vorsicht geprägten Handel zu Wochenbeginn zeichnen sich an den US-Aktienmärkten am Dienstag Gewinne ab. Rückenwind dürfte dabei…